Comments
Phase I of human clinical trails of Covaxin, the indigenously developed vaccine for Covid-19, has started at the Nizam’s Institute of Medical Sciences, Hyderabad.
Two volunteers were administered the first dose of the vaccine and their health condition will be closely monitored over the next six months. The next dose of the vaccine will be administered after a gap of 14 days. The focus will be on the antibodies that get generated in the system.
NIMS is among the 12 institutions across the country chosen by the Indian Council of Medical Research for vaccine trials.
The Covid vaccine has been derived from a strain of SARS-COV-2 isolated by the National Institute of Virology, Pune, and developed by Bharat Biotech India Limited, a Hyderabad-based vaccine company.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.